What are the survival rates for superior vena cava syndrome (SVCS)?

Updated: Mar 27, 2020
  • Author: Todd A Nickloes, DO, FACOS; Chief Editor: Vincent Lopez Rowe, MD  more...
  • Print

Clinical observations show that approximately 10% of patients with a bronchogenic carcinoma and 45% of patients with lymphoma treated with irradiation live at least 30 months. In contrast, patients with untreated malignant SVCS survive for only about 30 days. [5]  Survival for those who do not respond to treatment is similar.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!